Acta Scientific Orthopaedics (ISSN: 2581-8635)

Review Article Volume 5 Issue 5

Vitamin K, Osteoporosis, and Hip Fragility Fractures: A Review of Vitamin K Bone Impacts

Ray Marks*

Department of Health and Behavior Studies, Teachers College, Columbia University, New York, United States

*Corresponding Author: Ray Marks, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, United States.

Received: April 04, 2022; Published: April 21, 2022


Hip fragility fractures, which are very common injuries sustained by many older adults commonly lead to disabling hip joint osteoarthritis, premature death, or reduced life quality. As such and given the failure of most hip fracture preventive strategies to date, it appears more might be done to consider incorporating additional strategies into those already in place. This mini review examines whether: 1) Vitamin K, an important dietary compound that can also be partially synthesized intrinsically is a potentially important bone building or modeling determinant whose presence might influence the onset and progression of osteoporosis a key determinant of fragility fractures and 2) whether any evidence points to its application as being desirable among vulnerable aging adults with low vitamin K status or at risk for fragility fractures for other reasons. Based on the bulk of available data housed in PUBMED, it appears that vitamin K and its derivatives do have some promising albeit unproven impacts on bone metabolism, and hence possibly on osteoporosis, a pathological feature often found to prevail in hip fragility fracture injuries. It also appears that in addition to ensuring aging at risk adults have adequate vitamin K intakes and serum levels, efforts to solidify this promising line of inquiry may prove highly fruitful in efforts to prevent or reduce the persistent global age-associated hip fracture burden and its immense associated human and socioeconomic costs and ramifications.

Keywords: Bone Health; Fractures; Fragility; Hip Fractures; Osteoporosis; Prevention, Vitamin K


  1. Emmerson B., et al. "Hip Fracture Overview”. StatPearls. StatPearls Publishing (2021).
  2. Mears SC., et al. "A guide to improving the care of patients with fragility fractures, edition 2”. Geriatric Orthopaedic Surgery and Rehabilitation2 (2015): 58-120.
  3. Cooper C. "The epidemiology of fragility fractures: is there a role for bone quality?" Calcified Tissue International1 (1993): S23-S26.
  4. Eisman JA., et al. "Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention”. Journal of Bone and Mineral Research10 (2012): 2039-2046.
  5. McCarthy CJ., et al. "Assessment of previous fracture and anti-osteoporotic medication prescription in hip fracture patients”. Irish Journal of Medical Science 1 (2022): 247-252.
  6. Tsugawa N and M Shiraki. "Vitamin K nutrition and bone health”. Nutrients7 (2020): 1909.
  7. El Khassawna T., et al. "Effects of multi-deficiencies-diet on bone parameters of peripheral bone in ovariectomized mature rat”. PloS One8 (2013): e71665.
  8. Capozzi A., et al. "Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature”. Gynecological Endocrinology4 (2020): 285-288.
  9. Nino S., et al. "Vitamin D and metabolic supplementation in orthopedic trauma”. Orthopedic Clinics2 (2019): 171-179.
  10. Lönnroos E., et al. "Incidence of second hip fractures. A population-based study”. Osteoporosis international 18.9 (2007): 1279-1285.
  11. Wen L., et al. “Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review)”. Molecular Medicine Reports1 (2018): 3-15.
  12. Gigante A., et al. "Vitamin MK‐7 enhances vitamin D3‐induced osteogenesis in hMSCs: Modulation of key effectors in mineralization and vascularization”. Journal of Tissue Engineering and Regenerative Medicine6 (2015): 691-701.
  13. Rodrigues AM., et al. "Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fractures”. Bone6 (2012): 981-989.
  14. Binkley NC and JW Suttie. "Vitamin K nutrition and osteoporosis”. The Journal of Nutrition7 (1995): 1812-1821.
  15. Li W., et al. “Vitamin K 2 stimulates MC3T3‑E1 osteoblast differentiation and mineralization through autophagy induction”. Molecular Medicine Reports 19,5 (2019): 3676-3684.
  16. Palermo A., et al. “Vitamin K and osteoporosis: Myth or reality?” Metabolism: Clinical and Experimental70 (2017): 57-71.
  17. Akbari S and AA Rasouli-Ghahroudi. “Vitamin K and Bone Metabolism: A Review of the Latest Evidence in Preclinical Studies”. BioMed Research International (2018): 4629383.
  18. Hart JP., et al. "Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis”. The Journal of Clinical Endocrinology and Metabolism6 (1985):1268-1269.
  19. Hao G., et al. "Vitamin K intake and the risk of fractures: A meta-analysis”. Medicine17 (2017).
  20. Fusaro M., et al. "Vitamin K and osteoporosis”. Nutrients12 (2020): 3625.
  21. Hodges SJ., et al”. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck”. Bone6 (1991): 387-389.
  22. Tanaka N., et al. "Vitamin K deficiency, evaluated with higher serum ucOC, was correlated with poor bone status in women”. Journal of Physiological Anthropology1 (2020): 1-6.
  23. Vermeer C. "Vitamin K: the effect on health beyond coagulation-an overview”. Food and Nutrition Research1 (2012): 5329.
  24. Alonso N., et al”. Role of vitamin K in bone and muscle metabolism”. Calcified Tissue International(2022): 1-19.
  25. LeBlanc KE., et al”. Hip fracture: diagnosis, treatment, and secondary prevention”. American Family Physician12 (2014): 945-951.
  26. Shiraki, M., et al. "Recent advances in vitamin K-dependent Gla-containing proteins and vitamin K nutrition”. Osteoporosis and Sarcopenia1 (2015): 22-38.
  27. Zittermann A. "Effects of vitamin K on calcium and bone metabolism”. Current Opinion in Clinical Nutrition and Metabolic Care6 (2001): 483-487.
  28. Muszyńska M., et al. "Protective effects of vitamin K compounds on the proteomic profile of osteoblasts under oxidative stress conditions”. Molecules8 (2020): 1990.
  29. Ediz L., et al. "Complex regional pain syndrome: a vitamin K dependent entity?”. Medical Hypotheses3 (2010): 319-323.
  30. Bügel S. "Vitamin K and bone health in adult humans”. Vitamins and Hormones78 (2008): 393-416.
  31. Bitensky L., et al. "Circulating vitamin K levels in patients with fractures”. The Journal of Bone and Joint Surgery. British volume4 (1988): 663-664.
  32. Villa JKD., et al. "Effect of vitamin K in bone metabolism and vascular calcification: a review of mechanisms of action and evidences”. Critical Reviews in Food Science And Nutrition18 (2017): 3959-3970.
  33. Shah K., et al. "Vitamin K and bone health in older adults”. Journal of Nutrition in Gerontology And Geriatrics1 (2014): 10-22.
  34. Tucker KL. "Osteoporosis prevention and nutrition”. Current Osteoporosis Reports4 (2009): 111-117.
  35. Moore AE., et al. "Serum vitamin K1 (phylloquinone) is associated with fracture risk and hip strength in post-menopausal osteoporosis: a cross-sectional study”. Bone141 (2020): 115630.
  36. Iwamoto J., et al. "High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature”. Nutrition Research4 (2009): 221-228.
  37. Feskanich D., et al. "Vitamin K intake and hip fractures in women: a prospective study”. The American Journal of Clinical Nutrition1 (1999): 74-79.
  38. Mott A., et al. "Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials”. Osteoporosis International8 (2019): 1543-1559.
  39. Tasatargil A., et al. "Effects of vitamin K1 supplementation on vascular responsiveness and oxidative stress in a rat femoral osteotomy model”. Cell Biochemistry and Function: Cellular Biochemistry and Its Modulation By Active Agents or Disease5 (2007): 485-490.
  40. Apalset EM., et al. "Intake of vitamin K1 and K2 and risk of hip fractures: the Hordaland Health Study”. Bone5 (2011): 990-995.
  41. Vergnaud P., et al. "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study”. The Journal of Clinical Endocrinology and Metabolism3 (1997): 719-724.
  42. Stevenson M., et al. "Vitamin K to prevent fractures in older women: systematic review and e ttps:// evaluation”. Health Technology Assessment (Winchester, England)45 (2009): iii-xi.
  43. Chan R., et al. "No association between dietary vitamin K intake and fracture risk in Chinese community-dwelling older men and women: a prospective study”. Calcified Tissue International5 (2012): 396-403.
  44. Oni OOA, et al. "Serum osteocalcin and total alkaline phosphatase levels as prognostic indicators in tibial shaft fractures”. Injury1 (1989): 37-38.
  45. Bultynck C., et al. "Prevalence of vitamin K deficiency in older people with hip fracture”. Acta Clinica Belgica2 (2020): 136-140.
  46. Gigante A., et al. "Vitamin K and D association stimulates in vitro osteoblast differentiation of fracture site derived human mesenchymal stem cells”. Journal of Biological Regulators and Homeostatic Agents1 (2008): 35-44.
  47. Resmini G., et al. "Differential characteristics of bone quality and bone turnover biochemical markers in patients with hip fragility fractures and hip osteoarthritis: results of a clinical pilot study”. Aging Clinical and Experimental Research2 (2011): 99-105.
  48. Einhorn TA., et al. "Fracture healing and osteocalcin metabolism in vitamin K deficiency”. Clinical Orthopaedics and Related Research237 (1988): 219-225.
  49. Xiao H., et al. "Role of emerging vitamin K‑dependent proteins: growth arrest‑specific protein 6, Gla‑rich protein and periostin”. International Journal of Molecular Medicine3 (2021): 1-1.
  50. Iwamoto J., et al. "Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment”. Calcified Tissue International3 (2010): 234-241.
  51. Wang B., et al. "Is vitamin K2 a treatment choice for atypical femoral fractures in patients with secondary osteoporosis?” Journal of International Medical Research4 (2021): 03000605211001643.
  52. Dodds RA., et al. "Effects on fracture healing of an antagonist of the vitamin K cycle”. Calcified Tissue International1 (1984): 233-238.
  53. Bouckaert JH and AH Said. "Fracture healing by vitamin K”. Nature4716 (1960): 849-5.
  54. Sarkar N and S Bose. "Controlled delivery of curcumin and vitamin K2 from hydroxyapatite-coated titanium implant for enhanced in vitro chemoprevention, osteogenesis, and in vivo osseointegration”. ACS Applied Materials and Interfaces12 (2020): 13644-13656.
  55. Shimizu T., et al. "Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH1-34) for skeletal repair”. Bone64 (2014): 95-101.
  56. Weng S-J., et al. "Effects of combined menaquinone-4 and PTH1-34 treatment on osetogenesis and angiogenesis in calvarial defect in osteopenic rats”. Endocrine2 (2019): 376-384.
  57. Sifat M., et al. “Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures”. Aging 1 (2017): 256-285.
  58. Verma D., et al. “Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis”. Blood3 (2019): 227-238.
  59. Cheung AM., et al. "Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial”. PLoS Medicine10 (2008): e196.
  60. Atkins G., et al. “Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms”. American Journal of Physiology Cell Physiology6 (2009): C1358-1367.
  61. Rubinacci A. "Expanding the functional spectrum of vitamin K in bone. Focus on: “Vitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by γ-carboxylation-dependent and-independent mechanisms”. American Journal of Physiology-Cell Physiology6 (2009): C1336-C1338.
  62. Lanham-New SA. "Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment: symposium on ‘diet and bone health”. Proceedings of the Nutrition Society2 (2008): 163-176.
  63. Willems HME., et al. “Diet and exercise: a match made in bone”. Current Osteoporosis Reports. 15,6 (2017): 555-563.
  64. Simes DC., et al. “Vitamin K as a powerful micronutrient in aging and age-related diseases: pros and cons from clinical studies”. International Journal of Molecular Sciences17 (2019): 4150.
  65. Myneni VD and E Mezey. “Regulation of bone remodeling by vitamin K2”. Oral Diseases8 (2017): 1021-1028.
  66. Singh, MAF. "Exercise, nutrition and managing hip fracture in older persons”. Current Opinion in Clinical Nutrition and Metabolic Care1 (2014): 12-24.
  67. Mortensen SJ., et al. "Modifiable lifestyle factors associated with fragility hip fracture: a systematic review and meta-analysis”. Journal of Bone and Mineral Metabolism5 (2021): 893-902.
  68. Ramponi DR., et al. "Hip fractures”. Advanced Emergency Nursing Journal1 (2018): 8-15.
  69. Barceló M., et al. "Hip fracture and mortality: study of specific causes of death and risk factors”. Archives of Osteoporosis1 (2021): 1-8.
  70. Szulc P., et al. “Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women”. Journal of Clinical Investigation4(1993): 1769-1774.
  71. Inoue T., et al. "Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules”. Journal of Bone and Mineral Metabolism1 (2009): 66-75.
  72. Tal A., et al. “Treatment with vitamin K in hip fracture patients receiving warfarin”. Israel Medical Association Journal7 (2013):348-351.
  73. Giri TK., et al. "Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis”. International Journal for Vitamin and Nutrition Research(2019).
  74. Hamidi MS., et al. "Vitamin K and bone health”. Journal of Clinical Densitometry4 (2013): 409-413.
  75. Cockayne S., et al. "Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials”. Archives of Internal Medicine12 (2006): 1256-1261.
  76. Falcone TD., et al. "Vitamin K: fracture prevention and beyond”. PM and R3 (2011): S82-S87.
  77. Kaneki M., et al. "Pleiotropic actions of vitamin K: protector of bone health and beyond?” Nutrition7-8 (2006): 845-852.
  78. Azuma K and S Inoue. “Multiple modes of vitamin K actions in aging-related musculoskeletal disorders”. International Journal of Molecular Sciences11 (2019): 2844.
  79. McCann JC and BN Ames. "Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?”. The American Journal of Clinical Nutrition4 (2009): 889-907.
  80. Yaegashi Y., et al. "Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K”. European Journal of Epidemiology3 (2008): 219-225.
  81. Je SH., et al. "Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old”. Journal of Korean Medical Science8 (2011): 1093-1098.
  82. Mladěnka P., et al. “Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity”. Nutrition Reviews4 (2022): 677-698.
  83. Knapen MH., et al. “Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women”. Osteoporos International7(2007):963-972.
  1. Knapen MH., et al. “Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women”. Osteoporos International 24 (2013):2499-2507.
  1. Braam L AJLM., et al. "Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age”. Calcified Tissue International1 (2003): 21-26.
  2. Elshaikh, AO., et al. “Influence of Vitamin K on bone mineral density and osteoporosis”. Cureus 12 (2020): 10e10816.
  3. Wu Wei-Jie., et al. “A comparatively study of menaquinone-7 isolated from Cheonggukjang with vitamin K1and menaquinone-4 on osteoblastic cells differentiation and mineralization”. Food and Chemical Toxicology 131 (2019): 110540.
  4. Platonova, K., et al. “Dietary calcium and vitamin K are associated with osteoporotic fracture risk in middle-aged and elderly Japanese women, but not men: the Murakami Cohort Study”. The British Journal of Nutrition3 (2021): 319-328.


Citation: Ray Marks. “Vitamin K, Osteoporosis, and Hip Fragility Fractures: A Review of Vitamin K Bone Impacts".Acta Scientific Orthopaedics 5.5 (2022): 95-104.


Copyright: © 2022 Ray Marks. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US